The Aspergillosis Patients - PowerPoint PPT Presentation

Loading...

PPT – The Aspergillosis Patients PowerPoint presentation | free to download - id: 4119b7-ZDcxZ



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

The Aspergillosis Patients

Description:

If Posaconazole is required, an individual funding request will be sent to NCG. These requests are treated the same way as PCT requests. – PowerPoint PPT presentation

Number of Views:17
Avg rating:3.0/5.0
Slides: 11
Provided by: chr139
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: The Aspergillosis Patients


1
The Aspergillosis Patients Meeting
  • Speaker - Chris Harris
  • National Aspergillosis Centre Manager
  • Thursday 1st July 2010
  • Seminar Room 4
  • Education Research Centre
  • University Hospital South Manchester NHS
    Foundation Trust

2
The Aspergillosis Disease Groups
  • CPA
  • ABPA
  • SAFs
  • Aspergillus bronchitis
  • Aspergillus empyema
  • Invasive Aspergillus

3
The most common groups are
  • CPA
  • Patients in this group have some of their
    care and drugs funded by NCG.
  • ABPA and SAFS
  • Patients in these groups are not covered by
    NCG and therefore their care and any drugs
    required are paid for by the trust or their local
    PCT.

4
Costs
  • Itraconazole 1,400 per annum
  • Voriconazole - 30,000 per annum
  • Posaconazole - 42,000 per annum

5
The Process - PCTs (applicable to ABPA SAFS and
others.)
  • Decision is made to treat with a different
    antifungal drug.
  • Request is submitted to the finance department
    for IFR proforma.
  • Proforma is sent to Centre Manager.
  • Centre manager retrieves notes and other relevant
    documentation e.g results.

6
  • Notes and other documents sent to Doctor for
    completion.
  • Once proforma is completed it is submitted to
    finance department for directorate approval.
  • Proforma is sent to relevant PCT for
    consideration.
  • Await decision.

7
The Process - NCG (applicable to CPA only)
  • Decision is made to treat with a different
    antifungal drug.
  • If voriconazole is the next drug choice then this
    is approved for use by NCG.
  • If Posaconazole is required, an individual
    funding request will be sent to NCG.

8
  • These requests are treated the same way as PCT
    requests.
  • Individual case is discussed at a monthly
    meeting.
  • Await decision.

9
Points to consider whilst awaiting funding
  • IFR is an individual funding review.
  • Each patient is unique, decisions are made on you
    the individual - not as a group of people with
    the same disease.
  • Time scales vary from PCT to PCT.

10
What can you do to help this process?
  • Keep in touch.
  • Inform us of any change in your in your
    condition.
  • Keep a log this may help with the appeal
    process.
  • Phone two weeks before your appointment.
About PowerShow.com